The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted to grow at a robust CAGR of 10.1%, reaching US$ 878.9 Million in 2024 and an impressive US$ 1,5 ...

ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth ...

How Does AI Contribute to Better Sleep Habits? The intersection of artificial intelligence and sleep science has led to groundbreaking advancements in optimizing rest. This article delves into the ...

An implant for sleep apnea is one of the few CPAP alternatives. This article compares hypoglossal nerve stimulation and ...

Huxley Medical receives US FDA clearance for its cellular-enabled SANSA home sleep apnea test: Atlanta Friday, February 7, 2025, 10:00 Hrs [IST] Huxley Medical, a privately held m ...

Since iOS 18 was released in September 2024, Apple has introduced an unprecedented number of new features and improvements ...

According to a recent report by Future Market Insights (FMI), the global airway management devices market is projected to experience significant growth, reaching USD 2.2 billion by 2033, up from USD 1 ...

Portable Oxygen Concentrator Market. According to a revised research study by Future Market Insights, the global portable ...

Huxley Medical, a commercial-stage medical technology firm focused on streamlining detection of sleep and heart disorders, announced that the US Food and Drug Administration (FDA) has cleared the ...

ResMed Inc . (NYSE:RMD; ASX:RMD), a leading player in the sleep and respiratory care market, has demonstrated strong operational performance in recent quarters. However, the company faces potential ...

The American Heart Association says heart diseases are the leading cause of death in the US. Experts tell Digital Trends that ...